In vitro activities of a novel nanoemulsion against Burkholderia and other multidrug-resistant cystic fibrosis-associated bacterial species.
about
A novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without Th2 associated vaccine-enhanced diseaseGenomic Potential of Stenotrophomonas maltophilia in Bioremediation with an Assessment of Its Multifaceted Role in Our EnvironmentStenotrophomonas maltophilia: an emerging global opportunistic pathogenPotential applications and human biosafety of nanomaterials used in nanomedicineScreening a mushroom extract library for activity against Acinetobacter baumannii and Burkholderia cepacia and the identification of a compound with anti-Burkholderia activity.Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis.Nanoemulsion nasal adjuvant W₈₀5EC induces dendritic cell engulfment of antigen-primed epithelial cells.Update on antibiotics for infection control in cystic fibrosis.Social interactions in the Burkholderia cepacia complex: biofilms and quorum sensing.Achromobacter respiratory infections.Clinical and in vitro evidence for the antimicrobial therapy in Burkholderia cepacia complex infections.Novel glycopolymer sensitizes Burkholderia cepacia complex isolates from cystic fibrosis patients to tobramycin and meropenem.Nanoemulsion is an effective antimicrobial for methicillin-resistant Staphylococcus aureus in infected wounds.Antimicrobial activity of CHIR-090, an inhibitor of lipopolysaccharide biosynthesis, against the Burkholderia cepacia complex.Anti-bacterial TeNPs biosynthesized by haloarcheaon Halococcus salifodinae BK3.Triclosan resistance reversion by encapsulation in chitosan-coated-nanocapsule containing α-bisabolol as core: development of wound dressing.New strategies against Stenotrophomonas maltophilia: a serious worldwide intrinsically drug-resistant opportunistic pathogen.Optimization of niosomes for enhanced antibacterial activity and reduced bacterial resistance: in vitro and in vivo evaluation.A practical molecular identification of nonfermenting Gram-negative bacteria from cystic fibrosis.
P2860
Q21560951-3EE15A94-D088-4AFF-8505-B66C99503A7BQ26742183-F9BF3CEE-5D8E-4254-BBE2-AE95EC0327D8Q26995336-3F808224-01E5-49CB-9F8C-75A1DFAFAD5EQ32944368-A8BDB068-D67E-4EB9-8CBB-EE7D2AA02B4CQ33525706-F3B989E4-A499-4716-8986-7B1AC8E95FDBQ34309282-A1FFFE2A-5514-4B17-815C-CC38B608C469Q36565552-CE605B57-4001-4213-8003-327DCC817A19Q37608274-112549E0-8465-4E1C-B48F-B05BBAF54EC1Q37772892-7C05F583-D1B5-4037-9AA2-DB97E537027DQ38364314-F0289D1A-24AF-4E24-B5C0-EE202D3046C2Q38378454-F41E14D4-FD4F-4B65-B786-83C633443FD4Q40153501-76B2E2BD-F3AA-4FB0-98C1-620C12086065Q40235599-33C50D54-8074-43A6-81EC-1DA2161A2E2EQ42576819-9F10A97E-C2EB-4B07-803B-7D83D48DF8ABQ43024907-F5D5AC77-3719-4B28-A18B-43285B17F1B2Q43807100-6EE371ED-C1BF-4358-A22D-8B0F747CA403Q45099898-B5A0EC76-70E3-468B-B28B-04B5E3C8A734Q46202238-A4E3E646-68AD-436C-82B8-506F2B0DED30Q55040599-1C8F3A2D-CEB1-48BD-87B6-063ACCD21325
P2860
In vitro activities of a novel nanoemulsion against Burkholderia and other multidrug-resistant cystic fibrosis-associated bacterial species.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In vitro activities of a novel ...... -associated bacterial species.
@en
In vitro activities of a novel ...... -associated bacterial species.
@nl
type
label
In vitro activities of a novel ...... -associated bacterial species.
@en
In vitro activities of a novel ...... -associated bacterial species.
@nl
prefLabel
In vitro activities of a novel ...... -associated bacterial species.
@en
In vitro activities of a novel ...... -associated bacterial species.
@nl
P2093
P2860
P356
P1476
In vitro activities of a novel ...... -associated bacterial species.
@en
P2093
Bridget K Foster
James R Baker
John J LiPuma
Jordan C Keoleian
Linda M Kalikin
Paul E Makidon
Sivaprakash Rathinavelu
P2860
P304
P356
10.1128/AAC.00691-08
P407
P577
2008-10-27T00:00:00Z